2016 Annual Meeting of the American Association for the Study of Liver Diseases*

The 2016 hepatology meeting in Boston offered future solutions to some of my most vexing patient challenges.

Mark S. Sulkowski, MD Released: January 31, 2017

The treatment of NASH has challenges not seen in patients with HCV infection, but new trends are emerging.

Brent A. Neuschwander-Tetri, MD Released: March 10, 2017